Financhill
Back

Zymeworks Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
48

ZYME
Zymeworks

Last Price:
8.82
Seasonality Move:
16.62%
Sell
11

NBY
NovaBay Pharmaceuticals

Last Price:
0.08
Seasonality Move:
-9.04%
Sell
48
Zymeworks (ZYME) is a Sell

Is Zymeworks a Buy, Sell or Hold?

  • The current Zymeworks [ZYME] share price is $8.67. The Score for ZYME is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ZYME is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ZYME Stock Price Chart

What is Zymeworks's stock price today?

  • The Zymeworks share price today is $8.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZYME is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

ZYME Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 27.79 Sell
Chaikin Money Flow: -174442 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.18 - 10.56) Sell
Bollinger Bands (100): (9.32 - 11.5) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 29.13 Sell
Chaikin Money Flow: 2089154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.09 - 0.13) Sell
Bollinger Bands (100): (0.11 - 0.23) Sell

ZYME Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.08 Sell
20-day SMA: 9.65 Sell
50-day SMA: 10.81 Sell
200-day SMA: 8.83 Sell
8-day EMA: 9.07 Sell
20-day EMA: 9.6 Sell
50-day EMA: 10.19 Sell
200-day EMA: 9.46 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.09 Sell
20-day SMA: 0.1 Sell
50-day SMA: 0.13 Sell
200-day SMA: 0.35 Sell
8-day EMA: 0.09 Sell
20-day EMA: 0.1 Sell
50-day EMA: 0.13 Sell
200-day EMA: 0.6 Sell

Zymeworks Earnings Growth & ZYME Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and a decrease next year of $0.17 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.

Zymeworks Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):